Admed is strategically positioned to meet the needs of a diverse and dynamic global market. Our network of manufacturing facilities, research & development, and distribution hubs ensures that our products reach every corner of the world efficiently and effectively.
Our international branded generic business focuses on exporting to emerging and semi-regulated markets, and we are expanding into regulated markets such as the Afghanistan & Philippines.. Additionally, we have 6 new registration applications in progress and a robust pipeline with 10 product dossiers under development.
Europe : Combining local expertise with our global research capabilities to address European healthcare needs.
Latin America : Enhancing healthcare access and providing tailored solutions to meet regional demands.
Asia-Pacific : Leveraging our strong presence in the region to introduce new therapies and expand access to essential medications.
Our R&D teams are dedicated to developing groundbreaking therapies and solutions that address unmet medical needs. Through collaboration with leading academic institutions and healthcare organizations, we are at the forefront of pharmaceutical research and development.
Oncology : Developing targeted therapies for
cancer treatment
Neurology : Advancing treatments for
neurological disorders.
Cardiovascular Health: Innovating solutions
for heart disease & related conditions
Infectious Diseases Creating effective
treatments for emerging and existing infections.